Trending...
- Enable Accessible Haircare Wins Bronze at 2025 NACD Packaging Awards
- Deshawn White and Oceans Chest Unveil Country Single "What I Can" from Upcoming Album Let God and Let Go
- CoreIntegrator Announces Sage Intacct Approved A/P One Integration, Becoming an Official Sage Partner
FAYETTEVILLE, Ark. - ncarol.com -- Lineus Medical has been granted five additional international patents for its flagship product, SafeBreak® Vascular, in Korea, Brazil, Australia, India, and China. These patents strengthen Lineus Medical's intellectual property portfolio as the company continues expanding into major healthcare markets worldwide. They also mark a key milestone toward obtaining regulatory clearances and establishing distribution partnerships in these regions.
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on ncarol.com
"Securing these new patents is a critical step in advancing the global presence of SafeBreak," said Vance Clement, CEO of Lineus Medical. "They not only protect our product from being copied and add value to the company, they also provide us credibility in establishing relationships with new distribution partners in these countries."
About Lineus Medical:
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
References:
1. Data on File
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on ncarol.com
- Soulful Sounds Co-Owner Launches Holistic Wellness Nonprofit Event June 7th in Charlotte
- Coinbase recommends using Winner Mining Classic hashrate for the benefit of everyone
- Nieves Ministries Leads with Faith to Fortify Safety, Education, and Puerto Rican Culture in Colorado
- Deadline Extended: More Time to Submit Your Proposal for the OpenSSL Conference 2025
- Pulitzer Prize Nominated Lauren Coyle Rosen Releases New Album, Covers and Veils in Blue
"Securing these new patents is a critical step in advancing the global presence of SafeBreak," said Vance Clement, CEO of Lineus Medical. "They not only protect our product from being copied and add value to the company, they also provide us credibility in establishing relationships with new distribution partners in these countries."
About Lineus Medical:
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
References:
1. Data on File
Source: Lineus Medical
0 Comments
Latest on ncarol.com
- 6 Love Sports and Eight Sleep Announce Partnership Miami Women's Padel League Rebranded as the Eight Sleep Miami Women's Padel League by 6 Love Sports
- The TOBU RAILWAY X COFFEE PROJECT Supports Nikko Tourism and Fosters English Speaking Guides, Through November 27, 2026
- Al-Tabbaa & Hackett: Fixed Rates Improve For Savers
- Non-Citizen NY Travelers Face Extra Scrutiny at Local Airports: Attorney Robert Tsigler Featured in Gothamist
- $400 Million Run Rate in 2025 for Global Telcom Leader as a Result of Definitive Fintech Acquisition, Fast-Tracking $1 Billion Growth Plan: IQSTEL Inc
- Cassmer Ward Recognized Among Charlotte Business Journal's Top CEOs
- Chosen Launches Mobile Family Closet to Serve Foster, Adoptive, and Kinship Families Across Southeastern Wisconsin
- New Release Explores Grit, Wit, and Appalachian Life in We Saved Ourselves, Kinda
- WNC Roofing, LLC Opens Spartanburg, SC Location After a Decade of Serving the Upstate
- June Is Men's Health Month 2025:
- Velocity Performance Alliance Shifts Into High Gear with Luxury Auto Real Estate Platform Ahead of NASCAR Debut
- Floating Water Ramp for Pups is Still Making a Splash
- Bestselling Author Launches Book to Help Men Reclaim Their Power—Just in Time for Father's Day
- Castelletto Homes & International Garden Expert Introduce Edible Kitchen Gardens as New Home Feature
- UIFCA Wealth Academy's Revolutionary UIFCA(UFCA) Token Gains Momentum in AI-Powered Investment Market
- New Website Launch Positions TekTone Builders As Tulsa's Commercial Construction Leader
- Inframark Expands Its Capabilities and Presence in Arizona, Adding Wastewater Experts Mehall Contracting
- FilmHedge Is Letting A.I. Into the Deal Room—And Hollywood Will Never Be the Same
- This Artificial Intelligence Platform Could Change How Hollywood Gets Funded Forever
- $100 Million Financing Unlocked for Aggressive Acquisition and Growth Strategy Including Plan to Acquire Remote Lottery Platform: Stock Symbol: LTRY